Partnership to Drive Acceleration of Semiconductor Technology Development

SEMATECH, the international consortium of semiconductor manufacturers that conducts and sponsors cooperative research and development of advanced semiconductor technology, and UMC, a leading global semiconductor foundry, today announced UMC’s decision to join SEMATECH. The relationship will focus on research and development for exploratory technologies on 300mm wafers, including 22nm and beyond process generations.

SEMATECH President and CEO Dr. Michael Polcari said, “Our members join me in welcoming UMC to SEMATECH and we look forward to their contributions and technical insight from their perspective as a global leader in 300mm foundry services. UMC will be an important partner in accelerating the progress of R&D innovations into manufacturing solutions.”

Given SEMATECH’s excellent progress in its advanced technology and manufacturing programs in Albany and Austin, and with suppliers, universities, and research institutes around the world, strong synergies have been created to drive the cooperation with UMC. UMC is a natural partner for SEMATECH. In addition to large-scale 300mm production for 90nm and 65nm foundry products, UMC is currently qualifying its 45nm/40nm technology, and making good progress on 32nm/28nm technology.

“Partnering with SEMATECH is a win-win situation for both organizations,” said Dr. Shih Wei Sun, CEO of UMC. “The combination of UMC’s 300mm manufacturing experience and process technology expertise and SEMATECH’s wealth of knowledge in the field of semiconductor R&D will help the industry better handle the challenges of migration to next generation processes. We are excited about SEMATECH’s commitment to 300mm exploratory research and development and look forward to passing the benefits of this technology relationship to our customers.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.